Simultaneously, the high expression of immune checkpoint molecules like CTLA4 and TIGIT implies that Treg cells could establish an immunosuppressive state within the tumor microenvironment by suppressing the activation and proliferation of effector T cells, thereby facilitating tumor immune evasion. The gene discussed is TIGIT; the disease is neoplasm.